BACKGROUND: Transcranial Doppler ultrasonography (TCD) is used to predict stroke risk in children with sickle cell anemia (SCA), but has not been adequately studied in children under age 2 years. PROCEDURE: TCD was performed on infants with SCA enrolled in the BABY HUG trial. Subjects were 7-17 months of age (mean 12.6 months). TCD examinations were successfully performed in 94% of subjects (n = 192). RESULTS: No patient had an abnormal TCD as defined in the older child (time averaged maximum mean TAMM velocity > or =200 cm/sec) and only four subjects (2%) had velocities in the conditional range (170-199 cm/sec). TCD velocities were inversely related to hemoglobin (Hb) concentration and directly related to increasing age. CONCLUSION: Determination of whether the TCD values in this very young cohort of infants with SCA can be used to predict stroke risk later in childhood will require analysis of exit TCD's and long-term follow-up, which is ongoing (ClinicalTrials.gov number, NCT00006400). (c) 2009 Wiley-Liss, Inc.
BACKGROUND: Transcranial Doppler ultrasonography (TCD) is used to predict stroke risk in children with sickle cell anemia (SCA), but has not been adequately studied in children under age 2 years. PROCEDURE: TCD was performed on infants with SCA enrolled in the BABY HUG trial. Subjects were 7-17 months of age (mean 12.6 months). TCD examinations were successfully performed in 94% of subjects (n = 192). RESULTS: No patient had an abnormal TCD as defined in the older child (time averaged maximum mean TAMM velocity > or =200 cm/sec) and only four subjects (2%) had velocities in the conditional range (170-199 cm/sec). TCD velocities were inversely related to hemoglobin (Hb) concentration and directly related to increasing age. CONCLUSION: Determination of whether the TCD values in this very young cohort of infants with SCA can be used to predict stroke risk later in childhood will require analysis of exit TCD's and long-term follow-up, which is ongoing (ClinicalTrials.gov number, NCT00006400). (c) 2009 Wiley-Liss, Inc.
Authors: K Ohene-Frempong; S J Weiner; L A Sleeper; S T Miller; S Embury; J W Moohr; D L Wethers; C H Pegelow; F M Gill Journal: Blood Date: 1998-01-01 Impact factor: 22.113
Authors: Mary C Kral; Ronald T Brown; Paul J Nietert; Miguel R Abboud; Sherron M Jackson; George W Hynd Journal: Pediatrics Date: 2003-08 Impact factor: 7.124
Authors: Robert J Adams; Donald J Brambilla; Suzanne Granger; Dianne Gallagher; Elliott Vichinsky; Miguel R Abboud; Charles H Pegelow; Gerald Woods; Elizabeth M Rohde; Fenwick T Nichols; Anne Jones; Judith P Luden; Latonya Bowman; Susan Hagner; Knashawn H Morales; E Steve Roach Journal: Blood Date: 2004-01-29 Impact factor: 22.113
Authors: Isak Prohovnik; Anne Hurlet-Jensen; Robert Adams; Darryl De Vivo; Steven G Pavlakis Journal: J Cereb Blood Flow Metab Date: 2009-02-11 Impact factor: 6.200
Authors: R Adams; V McKie; F Nichols; E Carl; D L Zhang; K McKie; R Figueroa; M Litaker; W Thompson; D Hess Journal: N Engl J Med Date: 1992-02-27 Impact factor: 91.245
Authors: R J Adams; V C McKie; L Hsu; B Files; E Vichinsky; C Pegelow; M Abboud; D Gallagher; A Kutlar; F T Nichols; D R Bonds; D Brambilla Journal: N Engl J Med Date: 1998-07-02 Impact factor: 91.245
Authors: F Daniel Armstrong; T David Elkin; R Clark Brown; Penny Glass; Sohail Rana; James F Casella; Ram V Kalpatthi; Steven Pavlakis; Zhibao Mi; Winfred C Wang Journal: Pediatrics Date: 2013-01-06 Impact factor: 7.124
Authors: Colin R Deane; David Goss; Jack Bartram; Keith R E Pohl; Susan E Height; Naomi Sibtain; Jozef Jarosz; Swee Lay Thein; David C Rees Journal: Haematologica Date: 2010-03-10 Impact factor: 9.941
Authors: Courtney D Thornburg; Beatrice A Files; Zhaoyu Luo; Scott T Miller; Ram Kalpatthi; Rathi Iyer; Phillip Seaman; Jeffrey Lebensburger; Ofelia Alvarez; Bruce Thompson; Russell E Ware; Winfred C Wang Journal: Blood Date: 2012-08-22 Impact factor: 22.113